Background Our aim was to determine the impact of converting from tacrolimus to belatacept in patients with stable low eGFR early after kidney transplant. Methods This is a single center retrospective case control study. During this study period we had a clinical protocol to convert patients to belatacept if they had a stable but low GFR and they were at least 1-month posttransplant. Eligible patients had stable but low eGFR usually
http://ift.tt/2iL2u8u
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου